Vital Farms, Inc.
For the period ended Jun 28, 2026. Filed Aug 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 28, 2026 · Filed Aug 6, 2026
VITL$10.01-0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(Amounts in thousands)
| 26-Weeks Ended | ||
|---|---|---|
| June 28,2026 | June 29,2025 | |
| Cash flows from operating activities: | ||
| Net (loss) income | $(32,587) | $33,539 |
| Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities: | ||
| Depreciation and amortization | 7,597 | 6,727 |
| Reduction in the carrying amount of right-of-use assets | 7,581 | 3,691 |
| Stock-based compensation expense | 1,378 | 5,887 |
| Amortization of capitalized cloud computing arrangement costs | 1,397 | — |
| Amortization and accretion of available-for-sale securities | (526) | (296) |
| Amortization of debt issuance costs | 42 | 43 |
| Uncertain tax positions | (1,121) | 1,735 |
| Deferred taxes | (9,831) | (24) |
| Net realized losses on derivative instruments | 563 | 822 |
| Increase in inventory provision | 8,274 | 568 |
| Other | 1,331 | 725 |
| Net change in operating assets and liabilities | (30,010) | (48,904) |
| Net cash (used in) provided by operating activities | $(45,912) | $4,513 |
| Cash flows from investing activities: | ||
| Purchases of property, plant and equipment | (37,460) | (9,994) |
| Proceeds from the sale of available-for-sale securities | 43,002 | 404 |
| Maturities of available-for-sale securities | 22,000 | 7,890 |
| Purchases of derivative instruments | (261) | — |
| Proceeds from the settlement of derivative instruments | 202 | 264 |
| Proceeds from the sale of property, plant and equipment | 121 | 608 |
| Purchases of available-for-sale securities | — | (45,079) |
| Net cash provided by (used in) investing activities | $27,604 | $(45,907) |
| Cash flows from financing activities: | ||
| Proceeds from draw on JPMorgan Credit Facility | 30,000 | — |
| Proceeds from issuance of common stock under employee stock purchase plan | 404 | 379 |
| Proceeds from exercise of stock options | — | 3,649 |
| Repurchases of common stock | (35,151) | — |
| Payment of tax withholding obligation on vested restricted stock unit shares | (1,619) | (2,978) |
| Principal payments under finance lease obligations | (2,918) | (2,033) |
| Net cash used in financing activities | $(9,284) | $(983) |
| Net decrease in cash and cash equivalents | (27,592) | (42,377) |
| Cash and cash equivalents at beginning of the period | 48,831 | 150,601 |
| Cash and cash equivalents at end of the period | $21,239 | $108,224 |
| Supplemental disclosure of cash flow information: | ||
| Cash paid for interest | $460 | $410 |
| Cash paid for income taxes, net of amounts refunded | 2,001 | 11,772 |
| Supplemental disclosure of non-cash investing and financing activities: | ||
| Purchases of property, plant and equipment included in accounts payable and accrued liabilities | $11,904 | $25,590 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.